ViewRay (VRAY) reported earnings on Thur 8 Aug 19 (a/h)

ViewRay, Inc. designs, manufactures, and markets radiation therapy systems.

• Founded in 2004 
• HQ in Oakwood, Ohio

** charts before earnings **

 

** chart 4 months  after earnings **

ViewRay misses by $0.10, beats on revs; guides FY19 revs below consensus

Reports Q2 (Jun) loss of $0.32 per share, $0.10 worse than the S&P Capital IQ Consensus of ($0.22); revenues rose 83.5% year/year to $30.17 mln vs the $25.92 mln S&P Capital IQ Consensus.

Co issues downside guidance for FY19, sees FY19 revs of $80-95 mln vs. $118.55 mln S&P Capital IQ Consensus.

Expects total cash usage to be in the $80-90 mln range.